Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA.
CONCLUSIONS: The large number of reports that involved a concomitant medicine that was in contravention with prescribing guidelines indicates an increased need for efforts to support the safe prescribing of celecoxib.
PMID: 30929580 [PubMed - in process]
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research
More News: Australia Health | Canada Health | Cardiology | Cardiovascular | Celebrex | Databases & Libraries | Drugs & Pharmacology | Gastroenterology | Heart | Study | USA Health